Accelerating Cervical Cancer Prevention in Rwanda: a Two-Year Impact Assessment of an Integrated Policy Intervention

EClinicalMedicine 2026 Open access

Read full text
Authors: Daniel Sabushimike, Fatuma Gahongayire, Jean de Dieu Ntivuguruzwa, Jean Paul Hakizimana, Clarisse Usanzimfura, Marc Hagenimana, Jean de Dieu Hategekimana, Christian Nsanzabaganwa, Theoneste Maniragaba, M. Paczkowski, Adam Karpati
DOI: 10.1016/j.eclinm.2026.103961
Cited by: 1

Abstract

Cervical cancer remains a leading cause of cancer mortality among women in Rwanda. While HPV vaccination coverage is high, cervical cancer screening rates in 2023 were critically low at 18%, far below the WHO target of 70%. In response, Rwanda implemented a multi-component policy intervention. This study aimed to evaluate the implementation fidelity, early impact, and operational lessons from the nationwide scale-up of an integrated policy package designed to increase cervical cancer screening coverage in Rwanda.

Fields of Study & Subjects

Cervical Cancer and HPV Research Advances in Oncology and Radiotherapy Global Maternal and Child Health

Publication details

Journal / source
EClinicalMedicine
Publisher
Elsevier BV
Volume
94
Pages
103961–103961
Publication date
1 April 2026
Language
EN